ArticleJournal of pharmacokinetics and pharmacodynamics2026
Depot-central synchronization of a pharmacokinetic model with capacity-limited saturable absorption.
Article in Journal of pharmacokinetics and pharmacodynamics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Nonlinear drug absorption, driven by saturable transport or enzyme-mediated processes, significantly impacts drug disposition, yet its theoretical framework remains underdeveloped. This study investigates a one-compartment pharmacokinetic (PK) model featuring nonlinear saturable absorption and linear elimination under single- and multiple-dose regimens. We derive mathematical solutions for the concentration-time profiles in both scenarios. For multiple-dose administration, we identify a critical threshold where steady-state concentrations ([Formula: see text]) transition between constant and non-constant periodic solutions depending on the dosing regimen. Our analysis reveals that the Hill or Michaelis-Menten exponent α directly modulates oscillation amplitude, with higher values increasing plasma variability. Furthermore, we mathematically characterize key PK metrics, such as the Area Under the Concentration-time Curve (AUC) and the Fluctuation Index (FI), demonstrating that the relationship between single- and multiple-dose AUC is regimen-dependent, while the FI exhibits a dose-dependency that contrasts with classical first-order kinetics. These theoretical results are validated using clinical data for Cefatrizine. Overall, this work elucidates the intrinsic properties of nonlinear Hill-type or Michaelis-Menten absorption, providing a robust mathematical foundation for optimizing dosage regimen design.
Indexed as
Identifiers
42642682What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.